This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Marrone Bio Innovations stock | $1.15

Own Marrone Bio Innovations stock in just a few minutes.

Posted

Fact checked

Marrone Bio Innovations, Inc is an agricultural inputs business based in the US. Marrone Bio Innovations shares (MBII) are listed on the NASDAQ and all prices are listed in US Dollars. Marrone Bio Innovations employs 133 staff and has a trailing 12-month revenue of around USD$37.4 million.

How to buy shares in Marrone Bio Innovations

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Marrone Bio Innovations. Find the stock by name or ticker symbol: MBII. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Marrone Bio Innovations reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.15, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Marrone Bio Innovations, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Marrone Bio Innovations. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Marrone Bio Innovations share price

Use our graph to track the performance of MBII stocks over time.

Marrone Bio Innovations shares at a glance

Information last updated 2020-12-03.
Latest market close USD$1.15
52-week range USD$0.6101 - USD$1.5
50-day moving average USD$1.1577
200-day moving average USD$1.1673
Wall St. target price USD$1.99
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.187

Buy Marrone Bio Innovations shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Marrone Bio Innovations stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Marrone Bio Innovations price performance over time

Historical closes compared with the close of $1.15 from 2020-11-16

1 week (2020-11-25) -0.86%
1 month (2020-11-06) -3.36%
3 months (2020-09-04) -4.96%
6 months (2020-06-05) 10.58%
1 year (2019-12-05) 1.15
2 years (2018-12-04) -14.81%
3 years (2017-12-05) 17.35%
5 years (2015-12-04) -34.29%

Marrone Bio Innovations financials

Revenue TTM USD$37.4 million
Gross profit TTM USD$16.1 million
Return on assets TTM -12.52%
Return on equity TTM -109.51%
Profit margin -69.87%
Book value $0.152
Market capitalisation USD$178.4 million

TTM: trailing 12 months

Shorting Marrone Bio Innovations shares

There are currently 1.9 million Marrone Bio Innovations shares held short by investors – that's known as Marrone Bio Innovations's "short interest". This figure is 1.3% down from 1.9 million last month.

There are a few different ways that this level of interest in shorting Marrone Bio Innovations shares can be evaluated.

Marrone Bio Innovations's "short interest ratio" (SIR)

Marrone Bio Innovations's "short interest ratio" (SIR) is the quantity of Marrone Bio Innovations shares currently shorted divided by the average quantity of Marrone Bio Innovations shares traded daily (recently around 126531.87331536). Marrone Bio Innovations's SIR currently stands at 14.84. In other words for every 100,000 Marrone Bio Innovations shares traded daily on the market, roughly 14840 shares are currently held short.

However Marrone Bio Innovations's short interest can also be evaluated against the total number of Marrone Bio Innovations shares, or, against the total number of tradable Marrone Bio Innovations shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Marrone Bio Innovations's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Marrone Bio Innovations shares in existence, roughly 10 shares are currently held short) or 0.0371% of the tradable shares (for every 100,000 tradable Marrone Bio Innovations shares, roughly 37 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Marrone Bio Innovations.

Find out more about how you can short Marrone Bio Innovations stock.

Marrone Bio Innovations share dividends

We're not expecting Marrone Bio Innovations to pay a dividend over the next 12 months.

Marrone Bio Innovations share price volatility

Over the last 12 months, Marrone Bio Innovations's shares have ranged in value from as little as $0.6101 up to $1.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Marrone Bio Innovations's is 0.3008. This would suggest that Marrone Bio Innovations's shares are less volatile than average (for this exchange).

Marrone Bio Innovations overview

Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Regalia, a plant extract-based fungicidal biopesticide for plant disease and plant health; Grandevo, a bioinsecticide for insect and mite control; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Majestene, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, and reducing adult reproduction and egg hatch, as well as controls soil borne insects. The company also provides Stargus, a biofungicide to control plant diseases, such as Sclerotinia white molds, gray mold/bunch rot, and downy mildews; and Haven, a plant health product that is applied to the leaves of plants to reduce sun stress. In addition, it offers Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies. Additionally, the company provides Pro Farm products for increasing plant health, yield and quality; and Jet-Ag and Jet-Oxide, peroxyacetic acid-based plant health product lines that stops molds and bacteria on plants and other surfaces. Marrone Bio Innovations, Inc. serves agricultural and water treatment markets. The company provides its products directly through sales force, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site